Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC.

NCT04882462 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Nimotuzumab
DRUG: Sintilimab
DRUG: Chemotherapy drug

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

[object Object]
[object Object]